2012
|
Sign up to set email alerts
Ultrasound-Guided Intra-Articular Knee Injection in an Obese Patient
Abstract: A 35-yr-old woman was referred to our outpatient clinic for a right intra-articular knee aspiration and injection. She had a medical history notable for lymphedema and morbid obesity (Fig. 1). Her body mass index was recently calculated at greater than 60 kg/m(2). She had a history of four previous nonguided knee joint injections performed elsewhere that provided no significant improvement in pain. On physical examination, it was difficult to localize common knee joint bony landmarks, including the medial and … Show more
Search citation statements
Order By: Relevance
Paper Sections
Select...
7
2
1
1
Citation Types
0
9
0
0
Year Published
Range
2013
20132026
2026Publication Types
Select...
9
1
Relationship
0
10
Authors
Journals
Cited by 10 publications
(9 citation statements)
References 2 publications
0
9
0
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Fifty‐seven studies assessing injections in major joints were identified (see online supplementary Appendix 1) [5‐61]. A majority of the studies (49/57 [86%]) [6,7,9,11‐13,15,17‐25,27‐30,32‐51,53‐61] evaluated injections in a single joint, whereas 14% (8/57) [5,8,10,16,26,31,52,55] assessed injections in more than one joint.…”
Section: Results
mentioning
confidence: 99%
“…Fifty‐seven studies assessing injections in major joints were identified (see online supplementary Appendix 1) [5‐61]. A majority of the studies (49/57 [86%]) [6,7,9,11‐13,15,17‐25,27‐30,32‐51,53‐61] evaluated injections in a single joint, whereas 14% (8/57) [5,8,10,16,26,31,52,55] assessed injections in more than one joint. Thirty‐five percent (20/57) of the studies evaluated knee injections [8‐10,13,15,16,19‐23,26,31,32,36,37,48,52,56,57], 46% (26/57) evaluated glenohumeral (GH) joint injections [5,7,8,10,11,15‐17,24‐26,28,29,31,38‐40,42,43,46,47,49,52,54,60,61], 21% (12/57) evaluated hip injections [8,12,27,30,33,35,41,44,45,50,52,59,62], and 4% (2/57) evaluated sacroiliac (SI) joint injections [18,34].…”
Section: Results
mentioning
confidence: 99%
“…The results of the studies investigating major joint injection accuracy are summarized in Table 1. The level of evidence for a majority of the studies evaluating major joint USGI accuracy (15/23 [65%]) [5,8,9,15,16,18,20,21,23,27,30,32,34,36‐39,41,42,44‐46,49] or LMGI accuracy (28/28 [100%]) [5,7,9‐13,17,19,21‐26,28,31,32,36‐38,40,43,47,48,50,60,61] were level 1 or 2. The mean accuracy of GH, hip, and knee joint USGIs in studies with level 1 or 2 evidence ranged from 91%‐100% [5,8,9,15,18,21,23,32,36‐39,42,46,49], whereas the mean accuracy of LMGIs were between 64% and 81% [5,7,9‐13,17,19,21‐26,28,31,32,36‐38,40,43,47,48,50,60,61].…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Fifty‐seven studies assessing injections in major joints were identified (see online supplementary Appendix 1) [5‐61]. A majority of the studies (49/57 [86%]) [6,7,9,11‐13,15,17‐25,27‐30,32‐51,53‐61] evaluated injections in a single joint, whereas 14% (8/57) [5,8,10,16,26,31,52,55] assessed injections in more than one joint.…”
Section: Results
mentioning
confidence: 99%
“…Fifty‐seven studies assessing injections in major joints were identified (see online supplementary Appendix 1) [5‐61]. A majority of the studies (49/57 [86%]) [6,7,9,11‐13,15,17‐25,27‐30,32‐51,53‐61] evaluated injections in a single joint, whereas 14% (8/57) [5,8,10,16,26,31,52,55] assessed injections in more than one joint. Thirty‐five percent (20/57) of the studies evaluated knee injections [8‐10,13,15,16,19‐23,26,31,32,36,37,48,52,56,57], 46% (26/57) evaluated glenohumeral (GH) joint injections [5,7,8,10,11,15‐17,24‐26,28,29,31,38‐40,42,43,46,47,49,52,54,60,61], 21% (12/57) evaluated hip injections [8,12,27,30,33,35,41,44,45,50,52,59,62], and 4% (2/57) evaluated sacroiliac (SI) joint injections [18,34].…”
Section: Results
mentioning
confidence: 99%
“…The results of the studies investigating major joint injection accuracy are summarized in Table 1. The level of evidence for a majority of the studies evaluating major joint USGI accuracy (15/23 [65%]) [5,8,9,15,16,18,20,21,23,27,30,32,34,36‐39,41,42,44‐46,49] or LMGI accuracy (28/28 [100%]) [5,7,9‐13,17,19,21‐26,28,31,32,36‐38,40,43,47,48,50,60,61] were level 1 or 2. The mean accuracy of GH, hip, and knee joint USGIs in studies with level 1 or 2 evidence ranged from 91%‐100% [5,8,9,15,18,21,23,32,36‐39,42,46,49], whereas the mean accuracy of LMGIs were between 64% and 81% [5,7,9‐13,17,19,21‐26,28,31,32,36‐38,40,43,47,48,50,60,61].…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The level of evidence for a majority of the studies evaluating major joint USGI accuracy (15/23 (65%))5 8 9 15 16 18 20 21 23 27 30 32 34 36–39 41 42 44–46 49 or LMGI accuracy (28/28 (100%))5 7 9–13 17 19 21–26 28 31 32 36–38 40 43 47 48 50 60 61 were level 1 or 2. The mean accuracy of GH, hip and knee joint USGIs in studies with level 1 or 2 evidence ranged from 91% to 100%,5 8 9 15 18 21 23 32 36–39 42 46 49 whereas the mean accuracy of LMGIs were between 64% and 81% 5 7 9–13 17 19 21–26 28 31 32 36–38 40 43 47 48 50 60 61.…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Therefore, the use of long, lengthened needles on obese patients could improve aspiration success. In this context, Hurdle et al [ 32 ], successfully used a 22-gauge/ 3.5-inch spinal needle to aspirate SF from the knee of a morbidly obese patient under US guidance. Therefore, we hypothesized that the long, lengthened needles may have contributed to the success of aspiration in obese patients and those with mild knee effusion.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Fifty‐seven studies assessing injections in major joints were identified (see online supplementary Appendix 1) [5‐61]. A majority of the studies (49/57 [86%]) [6,7,9,11‐13,15,17‐25,27‐30,32‐51,53‐61] evaluated injections in a single joint, whereas 14% (8/57) [5,8,10,16,26,31,52,55] assessed injections in more than one joint.…”
Section: Results
mentioning
confidence: 99%
“…Fifty‐seven studies assessing injections in major joints were identified (see online supplementary Appendix 1) [5‐61]. A majority of the studies (49/57 [86%]) [6,7,9,11‐13,15,17‐25,27‐30,32‐51,53‐61] evaluated injections in a single joint, whereas 14% (8/57) [5,8,10,16,26,31,52,55] assessed injections in more than one joint. Thirty‐five percent (20/57) of the studies evaluated knee injections [8‐10,13,15,16,19‐23,26,31,32,36,37,48,52,56,57], 46% (26/57) evaluated glenohumeral (GH) joint injections [5,7,8,10,11,15‐17,24‐26,28,29,31,38‐40,42,43,46,47,49,52,54,60,61], 21% (12/57) evaluated hip injections [8,12,27,30,33,35,41,44,45,50,52,59,62], and 4% (2/57) evaluated sacroiliac (SI) joint injections [18,34].…”
Section: Results
mentioning
confidence: 99%
“…The results of the studies investigating major joint injection accuracy are summarized in Table 1. The level of evidence for a majority of the studies evaluating major joint USGI accuracy (15/23 [65%]) [5,8,9,15,16,18,20,21,23,27,30,32,34,36‐39,41,42,44‐46,49] or LMGI accuracy (28/28 [100%]) [5,7,9‐13,17,19,21‐26,28,31,32,36‐38,40,43,47,48,50,60,61] were level 1 or 2. The mean accuracy of GH, hip, and knee joint USGIs in studies with level 1 or 2 evidence ranged from 91%‐100% [5,8,9,15,18,21,23,32,36‐39,42,46,49], whereas the mean accuracy of LMGIs were between 64% and 81% [5,7,9‐13,17,19,21‐26,28,31,32,36‐38,40,43,47,48,50,60,61].…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The level of evidence for a majority of the studies evaluating major joint USGI accuracy (15/23 (65%))5 8 9 15 16 18 20 21 23 27 30 32 34 36–39 41 42 44–46 49 or LMGI accuracy (28/28 (100%))5 7 9–13 17 19 21–26 28 31 32 36–38 40 43 47 48 50 60 61 were level 1 or 2. The mean accuracy of GH, hip and knee joint USGIs in studies with level 1 or 2 evidence ranged from 91% to 100%,5 8 9 15 18 21 23 32 36–39 42 46 49 whereas the mean accuracy of LMGIs were between 64% and 81% 5 7 9–13 17 19 21–26 28 31 32 36–38 40 43 47 48 50 60 61.…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Therefore, the use of long, lengthened needles on obese patients could improve aspiration success. In this context, Hurdle et al [ 32 ], successfully used a 22-gauge/ 3.5-inch spinal needle to aspirate SF from the knee of a morbidly obese patient under US guidance. Therefore, we hypothesized that the long, lengthened needles may have contributed to the success of aspiration in obese patients and those with mild knee effusion.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Fifty‐seven studies assessing injections in major joints were identified (see online supplementary Appendix 1) [5‐61]. A majority of the studies (49/57 [86%]) [6,7,9,11‐13,15,17‐25,27‐30,32‐51,53‐61] evaluated injections in a single joint, whereas 14% (8/57) [5,8,10,16,26,31,52,55] assessed injections in more than one joint.…”
Section: Results
mentioning
confidence: 99%
“…Fifty‐seven studies assessing injections in major joints were identified (see online supplementary Appendix 1) [5‐61]. A majority of the studies (49/57 [86%]) [6,7,9,11‐13,15,17‐25,27‐30,32‐51,53‐61] evaluated injections in a single joint, whereas 14% (8/57) [5,8,10,16,26,31,52,55] assessed injections in more than one joint. Thirty‐five percent (20/57) of the studies evaluated knee injections [8‐10,13,15,16,19‐23,26,31,32,36,37,48,52,56,57], 46% (26/57) evaluated glenohumeral (GH) joint injections [5,7,8,10,11,15‐17,24‐26,28,29,31,38‐40,42,43,46,47,49,52,54,60,61], 21% (12/57) evaluated hip injections [8,12,27,30,33,35,41,44,45,50,52,59,62], and 4% (2/57) evaluated sacroiliac (SI) joint injections [18,34].…”
Section: Results
mentioning
confidence: 99%
“…The results of the studies investigating major joint injection accuracy are summarized in Table 1. The level of evidence for a majority of the studies evaluating major joint USGI accuracy (15/23 [65%]) [5,8,9,15,16,18,20,21,23,27,30,32,34,36‐39,41,42,44‐46,49] or LMGI accuracy (28/28 [100%]) [5,7,9‐13,17,19,21‐26,28,31,32,36‐38,40,43,47,48,50,60,61] were level 1 or 2. The mean accuracy of GH, hip, and knee joint USGIs in studies with level 1 or 2 evidence ranged from 91%‐100% [5,8,9,15,18,21,23,32,36‐39,42,46,49], whereas the mean accuracy of LMGIs were between 64% and 81% [5,7,9‐13,17,19,21‐26,28,31,32,36‐38,40,43,47,48,50,60,61].…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The level of evidence for a majority of the studies evaluating major joint USGI accuracy (15/23 (65%))5 8 9 15 16 18 20 21 23 27 30 32 34 36–39 41 42 44–46 49 or LMGI accuracy (28/28 (100%))5 7 9–13 17 19 21–26 28 31 32 36–38 40 43 47 48 50 60 61 were level 1 or 2. The mean accuracy of GH, hip and knee joint USGIs in studies with level 1 or 2 evidence ranged from 91% to 100%,5 8 9 15 18 21 23 32 36–39 42 46 49 whereas the mean accuracy of LMGIs were between 64% and 81% 5 7 9–13 17 19 21–26 28 31 32 36–38 40 43 47 48 50 60 61.…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Therefore, the use of long, lengthened needles on obese patients could improve aspiration success. In this context, Hurdle et al [ 32 ], successfully used a 22-gauge/ 3.5-inch spinal needle to aspirate SF from the knee of a morbidly obese patient under US guidance. Therefore, we hypothesized that the long, lengthened needles may have contributed to the success of aspiration in obese patients and those with mild knee effusion.…”
Section: Discussion
mentioning
confidence: 99%